Primary analysis and four-year follow-up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases. Di Giacomo AM, Chiarion-Sileni V, Del Vecchio M, Ferrucci PF, et al. Clin Cancer Res 2021 Jun 10. pii: 1078-0432.CCR-21-1046.

Read + Share

Amedeo Smart

Independent Medical Education

Di Giacomo AM, Chiarion-Sileni V, Del Vecchio M, Ferrucci PF, et al. Primary analysis and four-year follow-up of the phase III NIBIT-M2 trial in melanoma patients with brain metastases. Clin Cancer Res 2021 Jun 10. pii: 1078-0432.CCR-21-1046.
PMID: 34112708